Clinical Trials in Pittsburgh

Showing 1321-1340 of 10,050 trials

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

NCT06468202

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.

Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension

Ohio State University10,742 participantsStarted Oct 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +13 more locations

Active Not RecruitingPhase 3< 1 mile

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Gilead Sciences500 participantsStarted Dec 2017

Little Rock, Arkansas, United States • Palo Alto, California, United States • Pasadena, California, United States +105 more locations

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Find Trials by Condition in Pittsburgh

Ribociclib and Letrozole Treatment in Ovarian Cancer

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

SP Thoracic IDE Study

A Study of YL242 in Subjects With Advanced Solid Tumors

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors